Novo Nordisk A/S (NVO)
46.87
+1.11
(+2.43%)
USD |
NYSE |
May 07, 09:41
Novo Nordisk SG&A Expense (TTM) : 10.66B for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Evaxion AS | 1.491M |
| Ascendis Pharma A/S | 519.00M |
| Prothena Corp. Plc | 59.39M |
| Viking Therapeutics, Inc. | 48.28M |
| Cellectis SA | 19.83M |